TriSalus Life Sciences (TLSI) Treasury Shares (2020 - 2026)

TriSalus Life Sciences has reported Treasury Shares for 5 years, with the latest figure at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (changed N/A YoY), and the FY2025 full-year result was $1.8 million, up 297.65% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.8 million, down from $1.8 million in the prior quarter.
• The five-year high for Treasury Shares was $1.8 million in Q4 2025, with the low at $64173.0 in Q4 2023.
• Historically, Treasury Shares has averaged $1.0 million across 4 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2024 — Treasury Shares soared 615.81% — and 2025, when it jumped 297.65%.
• TriSalus Life Sciences' Treasury Shares stood at $64173.0 in 2023, then soared by 615.81% to $459357.0 in 2024, then jumped by 297.65% to $1.8 million in 2025, then retreated by 2.9% to $1.8 million in 2026.
• The last three Treasury Shares figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $459357.0 (Q4 2024), per Business Quant data.